RegMed Daily, Closing Bell, 2/15/12, close to a triple digit stock decline, with worst day so far of FY12
End of Day, Cause and Effect
EOD Commentary: Stocks added to losses … Wednesday following the Federal Reserve’s meeting minutes, amid ongoing worries over Greece. The S&P 500, Dow and the NASDAQ slid. The CBOE Volatility Index < widely considered the best gauge of fear in the market> climbed above … 21. The Fed minutes showed a few officials in January felt another round of bond buying would be needed before long to support theUS economy. The debate took place at a meeting in which the Fed decided to hold its benchmark interest rate at record lows until at least late 2014.
Closing Bell: The NASDAQ closed DOWN -16 (-0.55%) to 2,915.83. The Dow closed DOWN -97.33 (-0.76%) to 12,780.95.
Who’s up … 6 … at the close:
- Biolife Solutions (OTC BB: BLFS) +$0.399 <+66.50%> to $0.0999;
- Dendreon (DNDN) +$0.72 <+5,15%> to $14.71;
- Geron (GERN) + $0.02 <+1%> to $2.02;
- International Stem Cell (OTC BB: ISCO) +$0.02 <+4.33%> to $0.46;
- ReNeuron (RENE.L) +$018 <+3.59%> to $5.20;
- ThermoGenesis (KOOL) +$0.04 <+4.01%> to $1.09;
